The biological blueprint for depression and its cognitive effects
From enlarged brain regions to cognitive decline, studies aim to discover reliable indicators
2023-11-11
(Press-News.org) WASHINGTON — In studies that examine the depressed brain, researchers were able to identify specific genes, molecules, brain regions, and cognitive features that are associated with the disorder. The findings will be presented on Monday, November 13, 10–11 a.m. EST at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
More than 8% of adults in the United States suffer from severe depression, and the percentage is higher among specific groups, including adolescents and older adults. Depression is a complex condition that includes many different genetic components and environmental risk factors. Scientists are working to understand the exact mechanisms in the brain that correspond with the risk or development of depression in the hopes of developing earlier identification and more effective treatment options.
New findings show that:
Genetic variants seem to correspond with risks for depression as indicated by changes in brain structure in adolescents, in ways both sex-specific and not. (Yu Chen, Yale University)
In depression, distributed brain regions involved in attention and emotion processing (i.e., the salience network) have increased size/representation in adolescents — a potential biological target for early intervention. (Sanju Koirala, University of Minnesota)
Higher depressive symptoms have a stronger detrimental effect on reasoning in older adults, who were studied for several years. (Denise Park, University of Texas at Dallas)
Adolescents diagnosed with depression have unique epigenetic signatures in blood samples. (Cecilia Flores, McGill University)
“Identifying brain markers and risk factors for depression gets us closer to diagnosing and treating the disorder more effectively,” said Diego A. Pizzagalli, professor of psychiatry at Harvard Medical School and moderator of the press conference. “This research will ultimately allow us to pursue a more targeted approach, especially with regards to early intervention and personalized treatment strategies in vulnerable populations.”
This research was supported by national funding agencies including the National Institutes of Health and private funding organizations. Find out more about depression and the brain on BrainFacts.org.
Monday, November 13, 2023
10–11 a.m. EST
Walter E. Washington Convention Center, Room 202B
Press Conference Summary
These presentations identify dysregulations in the brain and peripheral blood that are correlated with depression. Three of the studies focus on adolescents and identify specific markers (genetic variants, brain networks, and microRNAs) that suggest a connection with risk for developing the disorder. The third study focuses on depression over time and establishes a connection between depression and decline in reasoning in older age.
Gray matter volumetric correlates of depression and genetic risks in children: preliminary evidence from the Adolescent Brain Cognition Development (ABCD) study
Yu Chen, yu.chen.yc838@yale.edu, Abstract PSTR098.07
Researchers studied 6,186 research participants (2,774 of which were girls ages 9–10) from the ABCD project to learn how genetic risks manifest in young people with depression; the study used voxel-based morphometry and computed polygenic risk scores (PRS) for depression.
For every participant, depression symptoms were assessed and PRS and gray matter volumes (GMV) across the brain were computed. In all subjects, more depressive symptoms and greater PRS were associated with smaller regional GMV across the brain, including frontal, parietal, temporal, insular and subcortical regions, with boys and girls alone showing most of GMV deficits in association with depression symptoms and PRS, respectively.
These findings suggest that, with regard to depression in children, there are brain structural markers shared by depression symptoms and genetic risks — but only some are sex-specific.
Individual variation in the size of salience network relates to depression
Sanju Koirala, koira019@umn.edu, Abstract PSTR098.16
Major depression has its origins in childhood, making it crucial to identify brain markers to prevent and treat the condition.
In a study of 5,530 adolescents from the Adolescent Brain Cognition Development (ABCD) Study, researchers found an increased size and representation of the salience network implicated in attention and emotion processing in participants with higher depressive symptoms.
This finding reveals a promising neural target for identifying and treating depression in youth.
Aging and depression trajectories on cognition
Denise Park, denise@utdallas.edu, Abstract PSTR307.10
Researchers investigated the relationship between depression and cognitive performance, predicting that depression would worsen with cognitive decline.
The study included 264 participants ages 20–89 who completed cognitive measures and questionnaires over an average of nearly four years. Analysis showed that baseline depressive symptoms peaked in young adulthood, declined through middle age, and returned to a smaller degree in very old age.
They also found that, for older adults, higher depressive symptoms resulted in a more detrimental effect on reasoning, which provides evidence of associations between depression and cognitive decline.
MicroRNA expression profiles from peripheral blood may serve as biomarkers for depression risk in children and adolescents
Cecilia Flores, cecilia.flores@mcgill.ca, Abstract PSTR225.12
Researchers are working to identify reliable molecular indicators for risk of depression using microRNA profiles in blood samples from adolescents, using a minimally-invasive method.
They identified several differentially expressed microRNAs in dry blood spot samples from adolescents diagnosed with clinical depression as well as in blood of children from an ethnically different background and who exhibit high depression scores. A common microRNA is elevated in both cohorts.
The identified microRNAs are highly expressed in the brain and their predicted gene targets are involved in neurodevelopmental and cognitive processes.
The levels of microRNAs linked to depression in blood samples can predict future severity of symptoms.
###
The Society for Neuroscience (SfN) is an organization of nearly 35,000 basic scientists and clinicians who study the brain and the nervous system.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-11-11
WASHINGTON — Innovative experimental approaches with human participants and animal models point to the effects of fear and stress on the brain — and suggest ways to ameliorate these impacts. The findings will be presented on Monday, November 13, 12:45–1:45 p.m. at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Fear and anxiety are normal, healthy emotional responses to some stimuli; however, there ...
2023-11-11
WASHINGTON — Psychedelic compounds such as psilocybin, a substance found in various mushroom species, are garnering more research support as novel treatments for psychiatric disorders, but questions remain concerning who they may help the most. The findings will be presented on Tuesday, November 14, 1–2 p.m. at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Psychiatric disorders, including phobias, post-traumatic stress disorder (PTSD), depression, and substance use disorder, represent a major public health issue. Current behavioral and pharmacological ...
2023-11-11
Research which considers the diversity of normal and diseased human populations is contributing to more resilient hypotheses regarding complex neuroscience processes, such as human brain development, autism spectrum disorders, and Alzheimer's disease. Several interwoven examples will be discussed on Sunday, November 12, 2–3 p.m. at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Considering the full spectrum of human variability — including gender, sex, race, ethnicity, and neurodiversity — is benefiting neuroscience at both the basic and translational ...
2023-11-11
WASHINGTON — Researchers have a better understanding of sleep disruption — particularly in the realm of sex-specific differences and cellular dysfunction — and are developing new research to study the interplay between sleep and memory. The findings will be presented on Tuesday, November 14, 10–11 a.m. EST at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Approximately one out of every three adults in the United States report not getting enough sleep. Despite years of research into sleep and memory, neuroscientists still do not ...
2023-11-11
For immediate release on Nov. 11, 2023 at 10:10 a.m. E.T.
A National Institutes of Health-supported study found that the type of transfusion approach used to support adults who developed anemia after a heart attack did not make a significant difference in their likelihood of having another heart attack or dying within 30 days. Participants in the trial were randomized to receive a red blood cell transfusion when their red blood cell counts were in a prespecified range of moderate anemia, which is considered a liberal approach, or when it was more severe, ...
2023-11-11
An international clinical trial led by physician Jeffrey L. Carson, distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, found that a liberal blood transfusion given to patients who have had a heart attack and have anemia may reduce the risk of a reoccurrence and improve survival rates. The results of the trial, Myocardium Infarction and Transfusion (MINT), were published today in the New England Journal of Medicine. Maria Mori Brooks, professor of epidemiology and biostatistics at the University of Pittsburgh School of Public Health, co-first authored the study.
“Transfusion threshold trials are important to help physicians inform decisions that provide ...
2023-11-11
About The Study: This secondary analysis of a randomized clinical trial validated a natural language processing model developed within a single healthcare system to identify heart failure hospitalizations. Further study is needed to determine whether natural language processing will improve the efficiency of future multicenter clinical trials by identifying clinical events at scale.
Authors: Scott D. Solomon, M.D., of Brigham and Women’s Hospital in Boston, is the corresponding author.
To access the embargoed study: ...
2023-11-11
Cleveland: Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes.
Semaglutide is primarily prescribed for adults with type 2 diabetes but is also approved for chronic weight management in adults with obesity or overweight and have at least one other health issue. In the trial, patients treated with semaglutide lost an average of 9.4% of their body weight and experienced improvements in other risk factors for cardiovascular disease.
Results ...
2023-11-11
Tokyo, Japan – Researchers from Tokyo Metropolitan University have identified key factors in the mechanism behind DNA repair in our bodies. For the first time, they showed that the “proofreading” portion of the DNA replicating enzyme polymerase epsilon ensured safe termination of replication at damaged portions of the DNA strand, ultimately saving DNA from severe damage. This new knowledge arms scientists with ways to make anti-cancer drugs more effective, and new diagnostic methods.
Our DNA is under attack. Every day, around 55,000 single-strand breaks (SSBs) appear in the strands making up DNA helices ...
2023-11-10
MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.
There is a general understanding that pets have a positive impact on one’s well-being. A new study by Michigan State University found that although pet owners reported pets improving their lives, there was not a reliable association between pet ownership and well-being during the COVID-19 pandemic.
The study, published in the Personality and Social Psychology Bulletin, assessed 767 people over three times in May 2020. The researchers took a mixed-method ...
LAST 30 PRESS RELEASES:
[Press-News.org] The biological blueprint for depression and its cognitive effects
From enlarged brain regions to cognitive decline, studies aim to discover reliable indicators
